
The only pill worth swallowing. Markets, memes, medicine, and mayhem — served straight, no chaser. Watch the video versions on YouTube : www.youtube.com/@TheShkreliPill/videos.
| Publishes | Daily | Episodes | 61 | Founded | 19 days ago |
|---|---|---|---|---|---|
| Categories | InvestingBusiness | ||||

In this episode, Martin critiques the surge in Palantir (PLTR) call options, calling it a degenerate gamble detached from fundamentals. He evaluates Duolingo’s stock, describing it as a strong but risky play, and provides an update on his ongoing pos... more
In this episode, Martin reveals his full trading record, showing how he achieved a 477% gain and the key moves behind his performance. He explains why he’s now all in on Biohaven stock and reviews IONQ’s latest earnings, highlighting what the results... more
In this episode, Martin breaks down his trading approach to Sarepta and reviews the latest earnings reports from AMD and Super Micro Computer (SMCI). He shares his candid opinions on Michael Burry’s market views and concludes with an in-depth review ... more
In this episode, Martin explains why he believes making money in a bear market can be straightforward with the right strategy. He shares his latest forecast for QURE, discusses his ongoing trades in Sarepta, and provides updated thoughts on Palantir’... more
In this episode, Martin examines how a single FDA-related hint caused QURE stock to surge and what it reveals about market sensitivity to biotech news. He also discusses his outlook on SPRB, speculating on when it could reach the $500 mark, and provi... more
In this episode, Martin shares that Sarepta has grown to represent 40% of his portfolio and explains the reasoning behind his conviction. He discusses the recent crash in QURE stock, provides an updated forecast for Biohaven, and analyzes what he vie... more
In this episode, Martin analyzes Walmart’s valuation and explains why he believes it signals a broader market shift toward caution and liquidity. He also reviews Reddit’s recent earnings, interpreting them as a warning sign for speculative stocks and... more
In this episode, Martin examines Berkshire Hathaway’s record $382 billion cash position and what it signals about market sentiment and opportunity. Through a compilation of key investing insights from recent streams, he shares the lessons and “gems” ... more
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #208 |










Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Rephonic provides a wide range of podcast stats for The Shkreli Pill. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Shkreli Pill and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Shkreli Pill, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for The Shkreli Pill, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers The Shkreli Pill has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
The Shkreli Pill launched 19 days ago and published 61 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for The Shkreli Pill from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of The Shkreli Pill. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.